Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amlodipine/candesartan cilexetil - Takeda

Next Previous
Drug Profile

Amlodipine/candesartan cilexetil - Takeda

Alternative Names: Amlodipine besylate/candesartan cilexetil - Takeda; Candesartan cilexetil/amlodipine; TCV-116/amlodipine besilate; TCV-116CCB; Unisia

Latest Information Update: 02 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Takeda
  • Class Antihypertensives; Benzimidazoles; Biphenyl compounds; Dihydropyridines; Heart failure therapies; Ischaemic heart disorder therapies; Small molecules; Tetrazoles
  • Mechanism of Action Angiotensin type 2 receptor antagonists; Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypertension

Most Recent Events

  • 02 Aug 2019 No development reported - Preregistration for Hypertension in Taiwan, Thailand (PO)
  • 08 Jun 2017 Takeda withdraws a phase III trial in Essential hypertension in China prior to enrolment due to business reasons (NCT02969265)
  • 22 Dec 2016 Chemical structure information added

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top